Session Videos and Slides

 

-

Friday, August 20, 2010

-

 

View Video
View Slides

Advocacy Summit: Moving Beyond the Confusion About Prostate Cancer Screening, Diagnosis and Treatment

There’s been a lot of recent controversy and confusion around PSA testing, which reinforces the importance of Us TOO’s longstanding advocacy priorities: clarifying the screening environment, and working for better imaging in diagnosis and treatment. This summit will serve as a platform for more comprehensive discussion on these topics.

Featured Presenters:
James L. Mohler, MD, Roswell Park Cancer Institute and Chair of the NCCN Guidelines Panel for Prostate Cancer
Durado Brooks, MD, MPH, Director of Prostate and Colorectal Cancers at the American Cancer Society
Paul F. Schellhammer, MD, FACS, Survivor, Past Chairman, American Urological Association
Faina Shtern, MD, President and CEO, AdMeTech Foundation Reactor

Comments From:
Skip Lockwood and Kevin Johnson, ZERO - The Project to End Prostate Cancer
Tom Ferrington, Prostate Health Education Network (PHEN)
Mike Scott, Prostate Cancer International
Scott Williams, Men’s Health Network
Lew Musgrove, National Alliance of State Prostate Cancer Coalitions

[object Object]

View Video
View Slides

Damon Arnold, MD, Director, IL Dept of Public Health, Survivor
Were Do We Stand With Prostate Cancer Today in Illinois and Nationwide

Damon T. Arnold, M.D., M.P.H., was named the 16th director of the Illinois Department of Public Health on October 1, 2007. Dr. Arnold has hosted International delegates from the Czech Republic, Poland, Russia and Taiwan. He also was appointed Adjunct Professor with Southern Illinois University, School of Medicine; University of Illinois, School of Medicine; University of Illinois, School of Public Health.

Prior to his appointment to director, Dr. Arnold was the medical director for bioterrorism and preparedness for the Chicago Department of Public Health. He has served in the Army National Guard for 25 years, holds the rank of colonel and, currently, is the guard’s commander of the Joint Task Force Medical Command in Springfield and the Illinois State Surgeon.

View Video
View Slides

Jonathan McDermed, PharmD, Director of Scientific and Clinical Affairs, IRIS Diagnostics
Current and Newsworthy Prostate Cancer Information You Need to Know

As one of the editors of the Us TOO monthly newsletter, the HotSheet, Jonathan McDermed, PharmD, is driven to contribute substantive content that adheres to the mission of the publication, which is to inform, educate and offer hope. He sifts through the ever-growing mountain of new data on an ongoing basis to determine what information is most important to the readers of the HotSheet.

 

  

View Video
View Slides

Us TOO's 20th Anniversary Celebration & Awards Dinner
Us TOO Leadership Panel - Us TOO 20 Years Later: Still Relevant. Still Involved.

Opening Remarks/Session Moderators:
Fred Mills
, Current Chairman of the Board, Us TOO International
Kay Lowmaster, Vice-Chair of the Board, Us TOO International
Tom Kirk, President & CEO, Us TOO Internaional

Panelists:
Beginning Years
Edward C. Kaps, Director Emeritus, Co-Founder, Us TOO International
Gerald Chodak, MD, Founding Physician Organizer, Us TOO Interational, Editor, www.ProstateVideos.com

Middle Years
Jim Kiefert, EdD, Director Emeritus, Immediate Past Chairman, Us TOO International
Lew Musgrove, Past Chairman, Us TOO International

Current & Future
Fred Mills, Current Chairman of the Board, Us TOO International
Tom Kirk, President & CEO, Us TOO Internaional

 

-

Saturday, August 21, 2010

-

View Video
View Slides

Mark A. Moyad, MD, MPH, Department of Urology, University of Michigan Medical Center, Jenkins/Pokempner endowed Director of Preventative & Alternative Medicine
Fad Diets, Dietary Supplements and Rx for your Health: What Works and What is Worthless from A to Z

Dr. Moyad is the primary author of over a hundred medical articles and numerous books, including his latest No BS Health Advice: a Step-by-Step Guide to What Works and What's Worthless.  In addition to his writings, he has maintained a consulting practice on complementary medicine for the past ten years.

[object Object]

View Video
View Slides

Charles “Snuffy” Myers, MD, President, Foundation for Cancer Research & Education (FCRE), Survivor
Taking Action Against Recurrence and Advanced Disease with Second Line Hormonal Therapy 

Medical oncologist and prostate cancer survivor, Dr. Charles "Snuffy" Myers was a key player in creating AZT, Suramin, and Phenylacetate while working at the National Institute of Health. With over 250 research papers published, Myers is one of the leading developers of today's prostate cancer canon on both the research and treatment side of the test tube. Prostate Forum is the educational arm of his world-renowned practice that is dedicated to providing men with the comprehensive care that saved his own life.

[object Object]

View Video
View Slides

Michael J. Dattoli, MD, Founder and Physician in Chief, Dattoli Cancer Center & Brachytherapy Research Institute
Radiation Therapy for Prostate Cancer: It’s Evolutionary, It’s Revolutionary

Radiation Oncologist Michael Dattoli, MD is one of the pioneers of prostate brachytherapy and a champion of using combined radiation therapies for the treatment of prostate cancer.  He is widely published on the subject of combined modalities and has coauthored three textbooks on Brachytherapy.  His research looking at the long-term outcomes for patients – particularly those with high risk disease– who have been treated with external radiation combined with Palladium-103 brachytherapy has resulted in the publication of the longest and best cure rate for prostate cancer in the medical literature.  His most recent publication appears in the July 2010 edition of the Journal of Oncology, and reports 16 years of look-back studies with an aggregate biochemical freedom from disease of 84%.  This number is impressive considering those are patients who were treated with technology which is now nearly 20 years old.

View Video
View Slides

E. Melissa Kaime, M.D., Captain, U. S. Navy Medical Corps; Director, Congressionally Directed Medical Research Programs
Update on the DOD Prostate Cancer Research Program & Consumer Reviewers

Captain E. Melissa Kaime assumed the role of Director of the Congressionally Directed Medical Research Programs (CDMRP) in June 2008 where she previously served as Deputy Director for 3 years.  Captain Kaime administers all facets of the Department of Defense breast cancer, prostate cancer, ovarian cancer, neurofibromatosis, tuberous sclerosis complex, autism, Gulf War illness, psychological health and traumatic brain injury, amyotrophic lateral sclerosis, deployment-related health, and other peer-reviewed medical research programs that total $4.8 billion.

[object Object]

View Video
View Slides

Paul F. Schellhammer, MD, FACS, Past Chairman, American Urological Association, Survivor
The Changing Landscape of Prostate Cancer Treatment 

Dr. Paul Schellhammer received his undergraduate education at the University of Notre Dame and his medical school training and Cornell Medical College in New York City. His surgical and urologic training were taken at the University Hospital of Cleveland in Cleveland, Ohio and the Medical College of Virginia, Richmond, Virginia. This was followed by a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. Subsequently he joined the practice of Devine Poutasse Fiveash Urology and became a faculty member of Eastern Virginia Medical School where he eventually achieved the rank of Professor and then also served as Chairman of the Department of Urology and Program Director of the Resident Training Program.

Dr. Schellhammer has made many contributions to the field of urologic oncology and published widely in that discipline, especially in prostate cancer. He serves on several editorial boards, and has served as a trustee of the American Board of Urology as its President. He has also served as President of the Society of Urologic Oncology, as President of his Mid-Atlantic Section of the American Urologic Association, as a member of the Board of Directors of the American Urologic Association, and President of the American Urologic Association 2007-2008.

[object Object]

View Video
View Slides

John P Mulhall, MD, Director, Sexual and Reproductive Medicine Program, Division of Urology, Memorial Sloan-Kettering Cancer Center
Meeting the Challenges of Intimacy and Incontinence - Panel Discussion

John P. Mulhull, MD, is a board-certified urologist and microsurgeon who specializes in sexual and reproductive medicine and surgery. He is the Director of Sexual and Reproductive Medicine Program, Division of Urology, at Memorial Sloan-Kettering Cancer Centers located throughout the New York City metropolitan area. As part of the Center’s Survivorship Initiative, a Male Sexual and Reproductive Medicine Program was established specifically to care for men who have suffered sexual difficulties or fertility problems as a result of their cancer or cancer treatment.

 [object Object]

View Video
View Slides


David and Kathie Houchens, Survivor and Spouse
Meeting the Challenges of Intimacy and Incontinence - Panel Discussion

David Houchens, PhD, a member of the Us TOO Board, and his wife, Kathie,will address intimacy issues from a couple’s perspective;

 

View Video
View Slides
 

 

Dennis Holt, Survivor, Drummer for the band Kansas
Meeting the Challenges of Intimacy and Incontinence - Panel Discussion

At a very fit 50 years old and someone who did regular exercise and check-ups, Dennis thought when he went into the doctor’s office that day; he would have nothing to worry about. However, with a long family history of prostate cancer, he knew he should keep a close watch on his PSA levels. Fortunately that day for Dennis, his urologist, L. Dean Knoll, MD, pressed him to have a biopsy even though his PSA level was only 4.4. During the exam, an aggressive prostate cancer was found.

Dr. Knoll recommended he have it removed laparoscopically since he was so young and the chances of post-op incontinence and erectile dysfunction (ED) were lower. After the surgery, Dr. Knoll told Dennis both good and bad news. The good was that they spared nerves and thus he would not be incontinent or impotent. The bad is that while they thought they got all of the cancer, some of his prostate was tucked away inside his bladder and therefore they would have to go back inside.

An open prostatectomy was scheduled that night to remove the prostate embedded in his bladder, and to reconstruct the bladder afterwards. Unfortunately for Dennis, this procedure could not spare the nerves in that region, leading to incontinence and erectile dysfunction. As an avid cyclist, runner and drummer, this news was devastating. Depression soon set in.

Dennis’ active lifestyle then changed due to the large number of pads he had to carry around with him. Every time he left the house, including his bike rides, he had to pack enough diapers in his bags, pants or coat pockets so as to not leak. Next, Dennis tried condom catheters to catch and hold urine. These led to skin irritations and the pain associated with removing the adhesive. He knew there had to be something out there to improve his situation. Dr. Knoll recommended the artificial sphincter and penile implant.

Dennis is an active advocate for men’s health and restored life after prostate cancer. He is a former drummer for the band Kansas, and plays for several others in his hometown of Nashville.

 

View Video
View Slides
 

Panel Session: Taking Passion to Action
Support & Education + Awareness & Advocacy = Empowerment & Action

Tom Kirk, President & CEO, Us TOO International
Fred Mills, Chairman, Us TOO International Board of Directors
Kay Lowmaster, MSW, LCSW, Vice-Chair, Us TOO International Board of Directors

 

 


Us TOO Home | Contact Us | Privacy Policy | Terms & Conditions | Disclaimer
All rights reserved. Us TOO International, Inc.